Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis.

Abstract

In 1994, the U.S. Cystic Fibrosis Foundation sponsored a consensus conference ([33][1]) on microbiology and infectious disease in patients with cystic fibrosis (CF), a homozygous recessive disease in individuals of Caucasian descent. The organization of that conference followed the recognition that